Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.

McLeod DS, Cooper DS, Ladenson PW, Ain KB, Brierley JD, Fein HG, Haugen BR, Jonklaas J, Magner J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI; The National Thyroid Cancer Treatment Cooperative Study Group..

Thyroid. 2014 Jan;24(1):35-42. doi: 10.1089/thy.2013.0062. Epub 2013 Sep 4.

2.

Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.

Nam HY, Paeng JC, Chung JK, Kang KW, Cheon GJ, Kim Y, Park DJ, Park YJ, Min HS, Lee DS.

Nuklearmedizin. 2014;53(2):32-8. doi: 10.3413/Nukmed-0604-13-06. Epub 2013 Nov 26.

PMID:
24276613
3.

Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.

Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T.

Ann Surg Oncol. 2014 Aug;21(8):2725-32. doi: 10.1245/s10434-014-3593-x. Epub 2014 Mar 5.

PMID:
24595799
4.

Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.

Böhm J, Kosma VM, Eskelinen M, Hollmen S, Niskanen M, Tulla H, Alhava E, Niskanen L.

Eur J Endocrinol. 1999 Nov;141(5):460-7.

5.

Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.

Wu X, Lun Y, Jiang H, Gang Q, Xin S, Duan Z, Zhang J.

Endocrine. 2014 Aug;46(3):554-60. doi: 10.1007/s12020-013-0121-x. Epub 2013 Dec 14.

PMID:
24338678
9.

High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.

Qin J, Yu Z, Guan H, Shi L, Liu Y, Zhao N, Shan Z, Han C, Li Y, Teng W.

Dis Markers. 2015;2015:648670. doi: 10.1155/2015/648670. Epub 2015 Oct 27.

10.

Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules.

Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW, Son HY.

Thyroid. 2010 Aug;20(8):885-91. doi: 10.1089/thy.2009.0384.

PMID:
20465529
11.

Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.

Lupoli GA, Okosieme OE, Evans C, Clark PM, Pickett AJ, Premawardhana LD, Lupoli G, Lazarus JH.

J Clin Endocrinol Metab. 2015 Jan;100(1):100-8. doi: 10.1210/jc.2014-2725.

PMID:
25322272
12.

[Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].

Vincze B, Sinkovics I, Keresztes S, Gergye M, Boér A, Remenár E, Péter I, Szentirmay Z, Kremmer T, Kásler M.

Magy Onkol. 2004;48(1):27-34. Epub 2004 Apr 23. Hungarian.

13.

Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.

Jo K, Kim MH, Lim Y, Jung SL, Bae JS, Jung CK, Kang MI, Cha BY, Lim DJ.

Eur J Endocrinol. 2015 Oct;173(4):489-97. doi: 10.1530/EJE-15-0344. Epub 2015 Jul 24.

14.

Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.

Kim SS, Lee BJ, Lee JC, Song SH, Kim BH, Son SM, Kim IJ, Kim YK, Kang YH.

Endocrine. 2011 Jun;39(3):259-65. doi: 10.1007/s12020-010-9430-5. Epub 2010 Dec 14.

PMID:
21161440
15.

Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.

Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, Lee DS, Lee MC, Cho BY.

Clin Endocrinol (Oxf). 2002 Aug;57(2):215-21.

PMID:
12153600
16.

Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.

Rubello D, Girelli ME, Casara D, Piccolo M, Perin A, Busnardo B.

J Endocrinol Invest. 1990 Oct;13(9):737-42.

PMID:
2292657
17.

Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.

Kamel N, Güllü S, Dağci Ilgin S, Corapçioğlu D, Tonyukuk Cesur V, Uysal AR, Başkal N, Erdoğan G.

Thyroid. 1999 Dec;9(12):1245-8.

PMID:
10646665
18.
19.
20.

Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.

Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT.

J Clin Endocrinol Metab. 1998 Apr;83(4):1121-7.

PMID:
9543128

Supplemental Content

Support Center